Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06568055
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-09
Brief Title:
A Study of Cytomegalovirus CMV Infection After Kidney Transplant in Adults in the United Kingdom
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Investigation of Refractory CMV Cytomegalovirus Infection or Disease After Kidney Transplantation Using UK United Kingdom National Registry of Rare Kidney Diseases RaDaR
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This observational study intends to retrospectively gather information on cytomegalovirus CMV infection management in the United Kingdom UK over a period of 7 years 2017-2024 The main aims of this study are the following
To estimate the overall prevalence and annual rate of adults with refractory CMV infection after a kidney transplant and describe how such CMV infections are treated
To describe how effective and well-tolerated the treatment was
To describe the demographic and clinical characteristics of adult participants with CMV infection refractory and non-refractory
In this study already existing data will be reviewed and analysed from a UK database called the Registry of Rare Kidney Diseases RaDaR NCT06065852 The study will only review data collected as part of routine clinical practice The study will not impact the standard medical care and treatment of participants
To estimate the overall prevalence and annual rate of adults with refractory CMV infection after a kidney transplant and describe how such CMV infections are treated
To describe how effective and well-tolerated the treatment was
To describe the demographic and clinical characteristics of adult participants with CMV infection refractory and non-refractory
In this study already existing data will be reviewed and analysed from a UK database called the Registry of Rare Kidney Diseases RaDaR NCT06065852 The study will only review data collected as part of routine clinical practice The study will not impact the standard medical care and treatment of participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None